Is PODD a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

271 people get PODD articles and Market Currents by email alert.

Get email alerts on PODD »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Insulet's Slowing Revenue Growth Could Pressure Stock
GAAP Analyst • Tue, Apr 16 • 2 Comments
Insulet Corporation Not Yet an Attractive Short Opportunity
Reggie Middleton • Thu, Jan 8, 2009 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

What Will Boost Medtech Stocks? Look For A Better Mousetrap, Says William Plovanic
Life Sciences Report • Fri, Feb 22
JPMorgan Healthcare Conference 2013: Ultra-Orphan Drug And Health IT Companies Lead The Way
Raymond Chung • Wed, Feb 6 • 4 Comments
Warren Buffett Invests In A Diabetes Future
Kevin Quon • Sun, Oct 14, 2012 • 17 Comments
4 Highly Liquid Small Cap Healthcare Stocks Set For Growth
ZetaKap • Tue, Sep 4, 2012 • 3 Comments
4 Healthcare Stocks Primed For Growth
ZetaKap • Fri, Jul 27, 2012
Analyzing Last Week's Noteworthy Insider Trades In Healthcare
GuruFundPicks • Mon, Apr 9, 2012
A Med-Tech Shopping List For Japanese Companies
Stephen Simpson • Tue, Mar 13, 2012 • 3 Comments
Cashing In On Diabetes: The Race To The Artificial Pancreas
Jessica King Holden • Wed, Mar 7, 2012 • 5 Comments
Biotechnology FDA Approval Catalyst Strategy
David Pope - S&P Capital IQ • Fri, Jan 13, 2012 • 7 Comments
Pure Play Diabetes Technology Companies Offer Little To No Value For Investor
Paul Nouri • Fri, Jan 6, 2012 • 11 Comments
Thomas Bailard Sells Costco, Buys Apple And Pfizer
Insider Monkey • Fri, Nov 18, 2011 • 1 Comment
Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA Capital
GuruFundPicks • Fri, Nov 18, 2011
10 Overvalued Healthcare Stocks
Follow My Alpha • Tue, Oct 25, 2011 • 2 Comments
10 Overvalued, Not-So-Profitable Stocks Vulnerable to Market Volatility
Follow My Alpha • Wed, Aug 17, 2011 • 2 Comments
8 Oversold, Shorted Stocks Reporting Earnings Next Week, Being Bought by Smart Money
Kapitall • Thu, Jul 28, 2011 • 4 Comments
The Big Money's Favorite Growth Stocks
Kapitall • Wed, May 11, 2011 • 5 Comments
Cramer's Mad Money - 12 Market Moving Events for the Coming Week (3/18/11)
SA Editor Miriam Metzinger • Mon, Mar 21, 2011 • 2 Comments
26 Rallying Stocks With Consecutive Quarters of Institutional Buying
Kapitall • Sun, Feb 20, 2011 • 1 Comment
10 High Growth Stocks Approaching an Inflection Point
Kapitall • Fri, Feb 4, 2011 • 1 Comment
10 Breakout Stocks With Rising Inventories
Kapitall • Thu, Jan 27, 2011 • 1 Comment

Insulet's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Mon, May 6
Insulet Corporation's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 28
Insulet Corporation Q2 2009 Earnings Call Transcript
Tue, Aug 4, 2009 • 1 Comment
Insulet Corporation Q3 2008 Earnings Call Transcript
Mon, Nov 24, 2008
Insulet Corporation, Q2 2008 Earnings Call Transcript
Tue, Aug 12, 2008
Insulet Corporation Q1 2008 Earnings Call Transcript
Tue, May 13, 2008
Insulet Corporation Q4 2007 Earnings Call Transcript
Tue, Mar 18, 2008

Insulet Corporation to Present at Upcoming Investor Conferences

Marketwire (May 15, 2013)
Insulet Reports First Quarter 2013 Results

Marketwire (May 6, 2013)
Insulet to Develop New Version of the OmniPod Insulin Pump for Use With Humulin R U-500 Concentrated Insulin for People With Type 2 Diabetes

Marketwire (May 2, 2013)
Insulet Corporation to Report First Quarter 2013 Financial Results on May 6, 2013

Marketwire (Apr 23, 2013)
Insulet Reports Fourth Quarter and Full Year 2012 Results

Marketwire (Feb 27, 2013)
Insulet Corporation to Present at the Raymond James 34th Annual Institutional Investors Conference

Marketwire (Feb 26, 2013)
Insulet Corporation to Report Fourth Quarter and Full Year 2012 Financial Results on February 27, 2013

Marketwire (Feb 7, 2013)
Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference

Marketwire (Feb 6, 2013)
Insulet Appoints Tracey H. Wielinski as VP, Global Regulatory/Clinical Affairs and Quality Assurance

Marketwire (Jan 23, 2013)
Insulet Corporation Announces the Sale of $85 Million of Common Stock

Marketwire (Jan 3, 2013)
Insulet Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference

Marketwire (Jan 2, 2013)
Next-Generation OmniPod(R) Insulin Pump Cleared by FDA

Marketwire (Dec 14, 2012)
Insulet Corporation to Present at Upcoming Investor Conferences

Marketwire (Nov 28, 2012)
Insulet Ranked Among the Fastest Growing Companies in North America on Deloitte's 2012 Technology Fast 500(TM)

Marketwire (Nov 15, 2012)
OmniPod Launches 'Suite D,' a New Resource for the Diabetes Online Community

Marketwire (Nov 12, 2012)
Insulet Reports Third Quarter 2012 Results

Marketwire (Nov 8, 2012)
Insulet Corporation to Present at Upcoming Investor Conferences

Marketwire (Nov 6, 2012)
Insulet Appoints John A. Fallon to Board of Directors

Marketwire (Oct 25, 2012)
Insulet Corporation to Report Third Quarter 2012 Financial Results on November 8, 2012

Marketwire (Oct 22, 2012)
Insulet Corporation to Present at the 10th Annual CL King Best Ideas Conference

Marketwire (Sep 7, 2012)

PODD vs. ETF Alternatives

Company Description

Currently, there's no company description for PODD.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, June 7, 7:57 AM Wunderlich downgrades Insulet (PODD) to Hold from Buy (price target $28). Comment! [Healthcare]
Tuesday, May 7, 12:52 PM Midday top 10 gainers: FSGI +28%. ARCI +27%. ININ +18%. MELI +18%. NLS +18%. PRTS +18%. REED +16%. PODD +14%. LAS +12%. MKTG +12%.
Midday top 10 losers: DCO -27%. RKUS -25%. GNK -24%. CUTR -23%. ARUN -22%. SNTA -15%. AMRI -12%. PIKE -12%. TA -12%. PTRY -11%. Comment! [On the Move]
Tuesday, May 7, 10:33 AM Insulet (PODD +10.6%) gets lifted today after its Q1 easily beat estimates. Revenue and gross profit increased by over 20% Y/Y, boosted by strong demand for its new OmniPod Insulin Pump. For the full year 2013, the company reiterates its revenue view of $240M to $255M, above the Street view of $248.4M. Comment! [Healthcare, Earnings, On the Move]
Monday, May 6, 4:30 PM Insulet (PODD): Q1 EPS of -$0.20 beats by $0.01. Revenue of $57.4M (+20% Y/Y) beats by $0.14M. Shares +5.2% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Wednesday, February 27, 4:27 PM Insulet (PODD): Q4 EPS of -$0.21 in-line. Revenue of $57.8M (+23% Y/Y) misses by $1.32M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, November 9, 2012, 4:06 PM Insulet (PODD +6.2%) finishes strong despite posting a mixed Q3 report yesterday. Revenue grew by 22% Y/Y, and investors are focusing on it's pipeline, which includes its OmniPod insulin pump currently awaiting FDA approval. Barrington thinks approval should come within 90 days. The firm expects the stock to outperform its peers once it's granted and reiterates an Outperform rating on the stock. Comment! [Healthcare, Earnings, On the Move]
Thursday, November 8, 2012, 4:46 PM Insulet (PODD): Q3 EPS of -$0.26 misses by $0.02. Revenue of $54.8M (+22.9% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Wednesday, August 8, 2012, 5:08 PM Insulet (PODD): Q2 EPS of -$0.30 misses by $0.05. Revenue of $51M (+58.4% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Wednesday, May 9, 2012, 4:23 PM Insulet (PODD): Q1 EPS of -$0.31 misses by $0.03. Revenue of $47.8M (+69% Y/Y) beats by $0.3M. (PR) Comment! [Earnings, Healthcare]
Monday, February 13, 2012, 1:51 PM Insulet (PODD +2.7%), a maker of insulin infusion devices for diabetics, is trading higher thanks to a bullish note from Barrington. While noting Insulet's recent Q4 report missed estimates, the firm still expects Insulet's OmniPod pump to act as a positive catalyst for shares. Comment! [Healthcare, On the Move, Quick Ideas]
Thursday, February 9, 2012, 5:35 PM Insulet (PODD): Q4 EPS of -$0.30 misses by $0.04. Revenue of $47.2M (+69.8% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Friday, September 23, 2011, 1:17 PM Insulet (PODD +1.9%) trades up after Wunderlich initiates the shares with a buy on valuation, saying the company's pending next-gen OmniPod launch will give it a competitive advantage to its peers. Comment! [Tech, On the Move]

ltfinger
Returning Upgrades (5/28/13): $PODD, $RAI, $RGA, $ROP, $SDRL, $SMG, $SNI, $SPY, $SSL, $STT, $TIF, $TMK, $USG, $VTI, $WAT, $XHB, $ZTS
May 30, 9:02 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Highly Liquid Small Cap Healthcare Stocks Set For Growth http://bit.ly/QiCgm0 $NAVB $PODD $SGNT $SQNM @ZetaKap
9/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Healthcare Stocks Primed For Growth http://bit.ly/OPKePj $AKRX $AUXL $PODD $SQNM @ZetaKap
7/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Channeling stock #2: PODD dropping from upper $15.75-$16.50 channel towards $13-$13.25 lower bound. Optionable.
11/5/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Small Cap Network
(PODD) gained a good amount in early trading today, and is looking good. http://tinyurl.com/mkah4a/
8/20/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

PODD Insulet Corporation

PODD

Insulet Corporation